Jerman Michael A. - 15 Jul 2025 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Reporting relationship: Director
Issuer ticker: TCRT
Reported as of: 15 Jul 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jul 2025, 17:35:05 UTC
Prior SEC filing: 29 Aug 2024
Next SEC filing: 26 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Melinda Lackey, Attorney-in-Fact

Key filing fact

Jerman Michael A. filed Form 4 for Alaunos Therapeutics, Inc. (TCRT) on 17 Jul 2025.

Key facts

This page summarizes Jerman Michael A.'s Form 4 filing for Alaunos Therapeutics, Inc. (TCRT).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 17 Jul 2025, 17:35.

Change

Previous filing in this sequence was filed on 29 Aug 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001979732 Primary reporting owner

Jerman Michael Allen

Relationship: Director
Address: C/O ALAUNOS THERAPEUTICS, INC., 2617 BISSONNET ST, SUITE 233, HOUSTON
Signature: /s/ Melinda Lackey, Attorney-in-Fact
Signature date: 17 Jul 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TCRT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +10,000
Change %
Price: $0.000000
Shares after: 10,000
Date: 15 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $3.40
Footnotes: F1

TCRT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +3,200
Change %
Price: $0.000000
Shares after: 3,200
Date: 15 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,200
Exercise price: $3.40
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

One-thirty sixth of the shares underlying the option vest in equal monthly installments measured from December 29, 2023, with the first vesting occurring on January 29, 2024, subject to the Reporting Person's continued service through each such date.

Footnote F2

One-twelfth of the Option vests each month on the monthly anniversary of July 15, 2025, with any amount that remains unvested on the date immediately preceding the Company's 2026 annual general meeting of stockholders vesting thereon. Vesting shall accelerate in full upon Optionholder's death or Disability or a Change of Control.